Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
暂无分享,去创建一个
J. Weber | Yuetsu Tanaka | Y. Tanaka | E. Hanon | R. Davis | C. Bangham | M. Osame | E Hanon | S Hall | G P Taylor | M Saito | R Davis | Y Tanaka | K Usuku | M Osame | J N Weber | C R Bangham | G. Taylor | M. Saito | Charles R. M. Bangham | S. E. Hall | J. Weber | K. Usuku | S. Hall | C. Bangham | Y. Tanaka | Mineki Saito | Ricardo Davis
[1] H. Inoko,et al. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells , 1992, Journal of virology.
[2] S. Izumo,et al. Analysis Of Htlv-I Proviral Load In 202 Ham/Tsp Patients And 243 Asymptomatic Htlv-I Carriers: High Proviral Load Strongly Predisposes To Ham/Tsp , 1998 .
[3] G. Lecatsas,et al. Human T-lymphotropic virus type I-associated myelopathy , 1991 .
[4] D. Kioussis,et al. Contribution of Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model , 1998, The Journal of experimental medicine.
[5] G. Boiteau,et al. J. Virol. Methods , 1996, Journal of Virological Methods.
[6] S. Jacobson,et al. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. , 1998, Journal of immunology.
[7] 馬止 裕. Close association between interleukin-2 receptor mRNA expression and human T cell leukemia/lymphoma virus type I viral RNA expression in short-term cultured leukemic cells from adult T cell leukemia patients , 1989 .
[8] G. de Thé,et al. An HTLV-I vaccine: why, how, for whom? , 1993, AIDS research and human retroviruses.
[9] Y. Itoyama,et al. Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy , 1988, Journal of the Neurological Sciences.
[10] J. Weber,et al. Quantification of proviral DNA load in human T-cell leukaemia virus type I infections. , 1998, Journal of virological methods.
[11] P Rudge,et al. In vivo cellular tropism of human T-cell leukemia virus type 1 , 1990, Journal of virology.
[12] M. Nowak,et al. Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[13] E. Sato,et al. Apoptosis of T Lymphocytes in the Spinal Cord Lesions in HTLV‐l-Associated Myelopathy: A Possible Mechanism to Control Viral Infection in the Central Nervous System , 1994, Journal of neuropathology and experimental neurology.
[14] Y. Tanaka,et al. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. , 1999, Journal of neurovirology.
[15] P. Höllsberg. Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I , 1999, Microbiology and Molecular Biology Reviews.
[16] T. Sugimura,et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Zinkernagel,et al. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.
[18] S. Yonehara,et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. , 1996, Journal of immunology.
[19] C. Bangham,et al. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. , 1992, Virology.
[20] D. Hafler,et al. Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. , 1997, Blood.
[21] A. Fauci,et al. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease , 1990, Nature.
[22] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[23] J. Weber,et al. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously , 1994, Journal of virology.
[24] B. Cullen. Regulation of human immunodeficiency virus replication. , 1991, Annual review of microbiology.
[25] A. Haase,et al. Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes , 1996, Annals of neurology.
[26] A. Kermode,et al. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. , 1996, Virology.
[27] T. Uchiyama. Human T cell leukemia virus type I (HTLV-I) and human diseases. , 1997, Annual review of immunology.
[28] M. Nakagawa,et al. Immunocytochemical Analysis of the Cellular Infiltrate in the Spinal Cord Lesions in HTLV‐I‐Associated Myelopathy , 1993, Journal of neuropathology and experimental neurology.
[29] D. Hafler,et al. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. , 1999, Journal of immunology.
[30] M. Nowak,et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Zinkernagel,et al. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. , 1995, The Journal of general virology.
[32] Y. Koyanagi,et al. Effect of human serum anti‐htlv antibodies on viral antigen induction in In vitro cultured peripheral lymphocytes from adult T‐CELL leukemia patients and healthy virus carriers , 1985, International journal of cancer.
[33] Yuetsu Tanaka,et al. Monoclonal antibody defining tax protein of human T-cell leukemia virus type-I. , 1989, The Tohoku journal of experimental medicine.
[34] R. Gallo,et al. Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy , 1991, Journal of virology.